CompletedNot Applicable

Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant

Italy2,769 participantsStarted 2014-01

Plain-language summary

All patients undergoing autologous or allogeneic stem cell transplant (SCT) for any underlying disease will be monitored for severe infections by gram negative bacteria (SIGNB) during the engraftment period. The follow up will be stopped at 4 months from the day of transplant. About 50 transplant centers will be involved in the study.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All consecutive patients submitted to autologous or allogeneic SCT at the Centers participating to the survey Signed written informed consent according to IGH/EU/GCP and national local laws. Without age limit Exclusion Criteria: Patients who did not sign written informed consent

What they're measuring

incidence of each type of Severe Infections by Gram Negative Bacteria

Timeframe: 4 months by stem cell transplant

Trial details

NCT IDNCT02088840

SponsorGruppo Italiano Trapianto di Midollo Osseo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-04

View on ClinicalTrials.gov More Complications of Organ Transplant Stem Cells trials